Search Results 2161-2170 of 20191 for Receptor

  1. Neurosurgery - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  2. Non-Alcoholic Fatty Liver Disease Progression Prevention Using Lisinopril - Mayo Clinic

    angiotensin II receptor antagonist (ARB) within 0-24 weeks prior to enrollment. - Glomerular filtration rate ≤ 30 ml/min (for both male and female ...

  3. A Study to Evaluate Autologous Bone Marrow Mononuclear Cells Using the CardiAMP™ Cell Therapy in Patients With Post Myocardial Infarction Heart Failure - Mayo Clinic

    Angiotensin converting enzyme (ACE) inhibitors or angiotension II receptor blockers (ARB) for patients with ACE inhibitor intolerance or nitrate/hydralazine at ...

  4. Study of Oral LOXO-338 in Patients With Advanced Blood Cancers - Mayo Clinic

    receptor-modified T cell (CAR-T) therapy within the past 60 days and with any of the following: - Active graft versus host disease (GVHD) - Cytopenias from ...

  5. Open-label, Multi-center, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR-BCMA T-cells (CT053) in Patients

    The purpose of this study is to evaluate Chimeric Antigen Receptor T Cells targeting BCMA in patients with myeloma. Participation eligibility. Participant ...

  6. Publications - PJ G. Thacker, Jr., M.D., M.H.A. - Mayo Clinic

    2013 Jan; 43: (2)196-201. View PubMed; Thacker PG, Binkovitz LA, Thomas KB. Deficiency of interleukin-1-receptor antagonist syndrome: a rare auto ...

  7. Publications - David J. Cangemi, M.D. - Mayo Clinic

    Lacy BE, Cangemi DJ. Opioids and the Gastrointestinal Tract: The Role of Peripherally Active micro-Opioid Receptor Antagonists in Modulating Intestinal ...

  8. Neurology - Clinical trials - Mayo Clinic

    Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

  9. ... RECEPTOR,317 301000593,HC SOMATOMEDIN/IGF1,287 301000594,HC SPECIFIC GRAVITY NOT URINE,33 301000597,HC ST2 SUPPRESSION OF TUMORIGENIC,173 301000598,HC ...

  10. Commencement Program - Mayo Clinic College of Medicine and Science

    Thesis: Estrogen Receptor Beta Elicits. Anti-Cancer Effects in Triple Negative. Breast Cancer Through Suppression of. NFkB Signaling. Position. Medical Student.